Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 February 2022 | Story NONSINDISO QWABE | Photo UFS Photo Archive
Prof Rodwell Makombe, Associate Professor in the Department of English on the Qwaqwa Campus.

Prof Rodwell Makombe, Associate Professor in the Department of English on the university’s Qwaqwa Campus, will be joining a prestigious group of more than 100 academic staff from African universities for this year’s University of Michigan African Presidential Scholars (UMAPS) programme.

Each year, the programme hosts more than 180 academics from different universities in Africa for a five-month fellowship, providing academics with access to the university’s research libraries and facilities, on-campus housing, health insurance, and a stipend to cover living expenses.

Fellowship an opportunity for collaboration and career growth 
 
The fellowship comes at just the right time for Prof Makombe, who said he is looking forward to mentorship for his growth and career development in a new environment and atmosphere. “I am very excited about this opportunity, which I think has come at the right time. It will expose me to a broad network of scholars, which I need for collaboration purposes, and it will also give me an opportunity to share my research and learn from the experiences of other scholars from different parts of the world. Given that I will be working closely with a faculty member of the university for the duration of the fellowship, the programme will also provide me with the mentorship that I need for my growth and career development.”
 
Apart from the exposure to broad academic and research scholars, he said he was looking forward to having the time and resources to finish writing his second book.

“I have just published my first book in October 2021, and I have already started doing research for my second book. The fellowship will give me time and space to focus on writing the book without the usual interruptions associated with my teaching responsibilities. The book focuses on cultures of resistance in post-Mugabe Zimbabwe. It is a sequel to my recent book,Cultural texts of resistance in Zimbabwe: Music, Memes, Media, which explores discursive resistance in Zimbabwe in the context of crisis.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept